Related Experiment Videos
Beyond Access: Structural Vulnerability and Type 2 Diabetes Disparities in Hispanic/Latino Populations
Ranjani Priya Ravinuthala1, Sriram Shyamkumar2, Keerthiga Ramesh Babu2
1University of North Texas, Denton, TX, USA. ranjanipriyaravinuthala@my.unt.edu.
Journal of Racial and Ethnic Health Disparities
|July 6, 2026
Summary
Type 2 Diabetes (T2D) disparities in Hispanic/Latino communities stem from structural issues, not just individual behavior. Addressing social determinants of health is crucial for long-term T2D equity.
Area of Science:
- Public Health
- Health Equity
- Diabetes Research
Background:
- Type 2 Diabetes (T2D) disproportionately affects Hispanic/Latino populations in the U.S.
- Disparities include higher prevalence, earlier onset, and increased complications compared to non-Hispanic Whites.
- Previous interventions overlooked structural factors influencing health.
Purpose of the Study:
- To examine how structural vulnerability and social determinants of health contribute to T2D inequities in Hispanic/Latino communities.
- To synthesize theory and review literature on T2D disparities.
Main Methods:
- Narrative review and theory synthesis.
- Literature search of PubMed, Scopus, and Google Scholar.
- Focused on healthcare access, language barriers, food insecurity, socioeconomic status, chronic stress, and systemic inequity.
Main Results:
- Structural factors like inadequate insurance, culturally discordant care, economic instability, immigration barriers, and neighborhood disadvantage drive T2D inequities.
- These factors impact diabetes risk, management, and outcomes.
Conclusions:
- Culturally tailored interventions show promise but are insufficient without addressing underlying structural inequities.
- Integrating Structural Vulnerability and Social Determinants of Health frameworks offers a comprehensive understanding of T2D disparities.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...